Norway· NO-ID_EA08D853-A6CC-43A4-8174-66DBD1E635A6

Parlodel

A bromocriptine product containing bromocriptine mesilate, registered in Norway by Meda. The same ATC class is registered in 8 of our 19 countries.

ATC N04BC01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedParlodelATCN04BC01REGISTER NO.NO-ID_EA08D853-A6CC-4…PACKS LISTED2CHECKEDSeptember 25, 2026

Where it is registered

Bromocriptine is registered in 8 of 19 countries.

Countries holding a registration under ATC N04BC01 (bromocriptine), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 4 of them publish a price we can compare per daily dose

Bromocriptine · ATC N04BC01

8 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bromocriptine costs, country by country.

Normalised to the WHO defined daily dose (40 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Bromocriptine · price per daily dose (40 mg)

USD · FX 28 Sept 2026

  • US United States$32.93 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Bromocriptine Mesilate
Manufacturer
Meda
Country
Norway (NO)
ATC code
N04BC01
ATC class
Bromocriptine
Defined daily dose
40 mg, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 2

  • no_merkevare_id
    ID_EA08D853-A6CC-43A4-8174-66DBD1E635A6
  • no_varenummer
    232834
    20

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

92 interactions on record for bromocriptine.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Bromocriptine · interactions on record

92 records

  • 3 severe
  • 87 moderate
  • 2 minor

Most severe, free to view

  • IsomethepteneA03AX10severe
  • LorcaserinA08AA11severe
  • PhenylpropanolaminA08AA13severe
  • LansoprazoleA02BC03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bromocriptine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bromocriptine products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Belgium · Parlodel
  • Bulgaria · Бромокриптин Медокеми
  • Cyprus · Medocriptine, Pirodal
  • Czechia · Medocriptine
  • Germany · Pravidel
  • Estonia · Bromocriptin Richter
  • Spain · Parlodel
  • France · Parlodel
  • United Kingdom (Northern Ireland) · Bromocriptine, Bromocriptine Brown & Burk Uk
  • Hungary · Bromocriptin Richter
  • Italy · Parlodel
  • Lithuania · Bromocriptin Richter
  • Luxembourg · Pravidel
  • Latvia · Bromocriptin Richter
  • Malta · Medocriptine
  • Netherlands · Parlodel
  • Poland · Bromocorn
  • Portugal · Bromocriptina Generis, Parlodel
  • Romania · Brocriptin
  • Sweden · Pravidel
  • Slovakia · Medocriptine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7ab001b6-c332-439f-b065-4dbd7e738bf5
GET /v1/drugs/7ab001b6-c332-439f-b065-4dbd7e738bf5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsel, hard",
  "source": "fest",
  "status": "A",
  "atc_name": "Bromokriptin",
  "merkevare_id": "ID_EA08D853-A6CC-43A4-8174-66DBD1E635A6",
  "name_form_strength": "Parlodel kaps 10 mg",
  "prescription_group": "C"
}

See everything about bromocriptine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.